These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 8262968)
21. Transcription factor Sp3 antagonizes activation of the ornithine decarboxylase promoter by Sp1. Kumar AP; Butler AP Nucleic Acids Res; 1997 May; 25(10):2012-9. PubMed ID: 9115370 [TBL] [Abstract][Full Text] [Related]
22. p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression. Uramoto H; Izumi H; Ise T; Tada M; Uchiumi T; Kuwano M; Yasumoto K; Funa K; Kohno K J Biol Chem; 2002 Aug; 277(35):31694-702. PubMed ID: 12080043 [TBL] [Abstract][Full Text] [Related]
23. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Gu W; Cechova K; Tassi V; Dalla-Favera R Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2935-9. PubMed ID: 8385351 [TBL] [Abstract][Full Text] [Related]
24. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024 [TBL] [Abstract][Full Text] [Related]
25. Characterization of cell-specific modulatory element in the murine ornithine decarboxylase promoter. Palvimo JJ; Partanen M; Jänne OA Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):993-8. PubMed ID: 8670180 [TBL] [Abstract][Full Text] [Related]
26. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317 [TBL] [Abstract][Full Text] [Related]
27. Opposite orientations of DNA bending by c-Myc and Max. Wechsler DS; Dang CV Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7635-9. PubMed ID: 1323849 [TBL] [Abstract][Full Text] [Related]
28. Specificity of DNA binding of the c-Myc/Max and ARNT/ARNT dimers at the CACGTG recognition site. Swanson HI; Yang JH Nucleic Acids Res; 1999 Aug; 27(15):3205-12. PubMed ID: 10454619 [TBL] [Abstract][Full Text] [Related]
29. Non-AP-1 tumor promoter 12-O-tetradecanoylphorbol-13-acetate-responsive sequences in the human ornithine decarboxylase gene. Kim YJ; Pan H; Verma AK Mol Carcinog; 1994 Jul; 10(3):169-79. PubMed ID: 8043198 [TBL] [Abstract][Full Text] [Related]
30. Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis. Shichiri M; Kato H; Doi M; Marumo F; Hirata Y Mol Endocrinol; 1999 Aug; 13(8):1353-63. PubMed ID: 10446908 [TBL] [Abstract][Full Text] [Related]
31. Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells to CPT-11. Pawlik CA; Iyengar RV; Krull EJ; Mason SE; Khanna R; Harris LC; Potter PM; Danks MK; Guichard SM Mol Ther; 2000 May; 1(5 Pt 1):457-63. PubMed ID: 10933967 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of tumor growth by direct intratumoral gene transfer of herpes simplex virus thymidine kinase gene with DNA-liposome complexes. Sugaya S; Fujita K; Kikuchi A; Ueda H; Takakuwa K; Kodama S; Tanaka K Hum Gene Ther; 1996 Jan; 7(2):223-30. PubMed ID: 8788173 [TBL] [Abstract][Full Text] [Related]
33. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc. Gupta K; Anand G; Yin X; Grove L; Prochownik EV Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857 [TBL] [Abstract][Full Text] [Related]
34. A novel glucocorticoid regulatory unit mediates the hormone responsiveness of the beta1-adrenergic receptor gene. Tseng YT; Stabila JP; Nguyen TT; McGonnigal BG; Waschek JA; Padbury JF Mol Cell Endocrinol; 2001 Jul; 181(1-2):165-78. PubMed ID: 11476950 [TBL] [Abstract][Full Text] [Related]
35. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Blackwood EM; Eisenman RN Science; 1991 Mar; 251(4998):1211-7. PubMed ID: 2006410 [TBL] [Abstract][Full Text] [Related]
36. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation. Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152 [TBL] [Abstract][Full Text] [Related]
37. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Desbarats L; Gaubatz S; Eilers M Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028 [TBL] [Abstract][Full Text] [Related]
38. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression. Si J; Yu X; Zhang Y; DeWille JW Mol Cancer; 2010 Apr; 9():92. PubMed ID: 20426839 [TBL] [Abstract][Full Text] [Related]
39. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors. Nair SK; Burley SK Cell; 2003 Jan; 112(2):193-205. PubMed ID: 12553908 [TBL] [Abstract][Full Text] [Related]
40. A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins. Billaud M; Isselbacher KJ; Bernards R Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2739-43. PubMed ID: 8464883 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]